Andrew S. Fein Analyst PerformanceAnalyst at HC WainwrightAndrew S. Fein is a stock analyst at HC Wainwright in the healthcare sector, covering 27 publicly traded companies. Over the past year, Andrew S. Fein has issued 49 stock ratings, including buy and hold recommendations. While full access to Andrew S. Fein's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Andrew S. Fein's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings59 Last 1 YearsBuy Recommendations87.93% 51 Buy RatingsCompanies Covered27 Unique Companies Ratings Distribution58RatingsDistribution of strong buy, buy, hold, and sell ratings by Andrew S. Fein.RatingPercentageCount Strong Buy0.0%0 ratings Buy87.9%51 ratings Hold12.1%7 ratings Sell0.0%0 ratingsOut of 58 total stock ratings issued by Andrew S. Fein at HC Wainwright, the majority (87.9%) have been Buy recommendations, followed by 12.1% Hold.Best & Worst CallsBest Call0000.0%KYMRSep 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%MTVASep 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ27 companiesAndrew S. Fein, an analyst at HC Wainwright, currently covers 27 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare27 companies100.0%Andrew S. Fein of HC Wainwright specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY23 companies85.2%PHARMACEUTICALS4 companies14.8% Andrew S. Fein's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsLQDALiquidia10/2/2026Lower Price Target$27.99$58.00Buy$0.0000.00% ROIAMLXAmylyx Pharmaceuticals8/18/2026Boost Price Target$33.16$55.00Buy$0.0000.00% ROILQDALiquidia7/24/2026Set Price Target$88.44$36.00$0.0000.00% ROIMTVAMetaVia7/10/2026Reiterated Rating$1.73Buy$0.0000.00% ROIBCRXBioCryst Pharmaceuticals6/30/2026Reiterated Rating$9.86$32.00Buy$0.0000.00% ROIFULCFulcrum Therapeutics6/2/2026Downgrade$6.42$3.00Neutral$0.0000.00% ROICPRXCatalyst Pharmaceuticals5/28/2026Downgrade$31.32$31.50Neutral$0.0000.00% ROIWVEWAVE Life Sciences5/19/2026Lower Price Target$6.40$13.00Buy$0.0000.00% ROIMTVAMetaVia5/18/2026Reiterated Rating$1.11$20.00Buy$0.0000.00% ROILQDALiquidia5/12/2026Boost Price Target$53.30$67.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. MDGLMadrigal Pharmaceuticals5/6/2026Reiterated Rating$502.47$620.00Buy$0.0000.00% ROIKALVKalVista Pharmaceuticals5/1/2026Downgrade$26.66$27.00Neutral$0.0000.00% ROIAURAAura Biosciences4/29/2026Boost Price Target$6.96$24.00Buy$0.0000.00% ROITARAProtara Therapeutics4/29/2026Boost Price Target$5.06$27.00Buy$0.0000.00% ROIWVEWAVE Life Sciences4/14/2026Lower Price Target$7.26$18.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences4/7/2026Boost Price Target$132.48$215.00Buy$0.0000.00% ROIBIIBBiogen4/2/2026Boost Price Target$183.78$237.00Buy$0.0000.00% ROIUTHRUnited Therapeutics3/31/2026Boost Price Target$583.78$660.00Buy$0.0000.00% ROIMTVAMetaVia3/27/2026Lower Price Target$1.27$20.00Buy$0.0000.00% ROIDNLIDenali Therapeutics3/26/2026Boost Price Target$22.47$42.00Buy$0.0000.00% ROIINSMInsmed3/26/2026Boost Price Target$149.18$245.00Buy$0.0000.00% ROIAMLXAmylyx Pharmaceuticals3/25/2026Reiterated Rating$13.66$34.00Buy$0.0000.00% ROIPVLAPalvella Therapeutics3/24/2026Boost Price Target$115.73$270.00Buy$0.0000.00% ROIVRTXVertex Pharmaceuticals3/10/2026Boost Price Target$460.87$641.00Buy$0.0000.00% ROILQDALiquidia3/6/2026Boost Price Target$34.52$55.00Buy$0.0000.00% ROIAMLXAmylyx Pharmaceuticals3/4/2026Boost Price Target$14.67$34.00Buy$0.0000.00% ROIWVEWAVE Life Sciences3/2/2026Reiterated Rating$13.93$30.00Buy$0.0000.00% ROIUTHRUnited Therapeutics2/26/2026Boost Price Target$503.28$600.00Buy$0.0000.00% ROIINSMInsmed2/23/2026Reiterated Rating$164.91$230.00Buy$0.0000.00% ROIVRTXVertex Pharmaceuticals2/13/2026Boost Price Target$465.02$518.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences2/12/2026Lower Price Target$137.44$192.00Buy$0.0000.00% ROIAMLXAmylyx Pharmaceuticals2/10/2026Boost Price Target$14.22$28.00Buy$0.0000.00% ROIBIIBBiogen2/9/2026Boost Price Target$201.18$228.00Buy$0.0000.00% ROIMTVAMetaVia1/6/2026Boost Price Target$8.21$40.00Buy$0.0000.00% ROIINSMInsmed12/18/2025Lower Price Target$165.88$230.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences12/17/2025Boost Price Target$148.74$198.00Buy$0.0000.00% ROIBCRXBioCryst Pharmaceuticals12/15/2025Boost Price Target$7.58$32.00Buy$0.0000.00% ROIKMDAKamada12/9/2025Boost Price Target$6.73$13.00Buy$0.0000.00% ROIFULCFulcrum Therapeutics12/8/2025Boost Price Target$8.90$25.00Buy$0.0000.00% ROIMDGLMadrigal Pharmaceuticals11/21/2025Boost Price Target$556.75$620.00Buy$0.0000.00% ROISmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad)A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.Click here to learn this company's name for free todayARCTArcturus Therapeutics11/11/2025Lower Price Target$8.69$9.00Neutral$0.0000.00% ROIMDGLMadrigal Pharmaceuticals11/11/2025Boost Price Target$524.24$568.00Buy$0.0000.00% ROIPRTAProthena11/7/2025Boost Price Target$10.19$30.00Buy$0.0000.00% ROIPVLAPalvella Therapeutics11/6/2025Boost Price Target$75.75$190.00Buy$0.0000.00% ROIDBVTDBV Technologies10/29/2025Reiterated Rating$14.55$20.00Buy$0.0000.00% ROIARCTArcturus Therapeutics10/24/2025Reiterated Rating$12.00$12.00Neutral$0.0000.00% ROIFULCFulcrum Therapeutics10/20/2025Reiterated Rating$8.99$12.00Buy$0.0000.00% ROIPRTAProthena10/7/2025Boost Price Target$9.86$20.00Buy$0.0000.00% ROILQDALiquidia10/6/2025Reiterated Rating$22.43$35.00Buy$0.0000.00% ROIETNB89BIO9/19/2025Downgrade$14.96$14.50Neutral$0.0000.00% ROIKYMRKymera Therapeutics9/18/2025Boost Price Target$48.12$70.00Buy$000.0000.00% ROITERNTerns Pharmaceuticals9/4/2025Initiated Coverage$7.44$7.44Neutral$0.0000.00% ROIMTVAMetaVia9/4/2025Initiated Coverage$7.36$132.00Buy$0.0000.00% ROIMDGLMadrigal Pharmaceuticals9/4/2025Initiated Coverage$435.27$500.00Buy$000.0000.00% ROIARCTArcturus Therapeutics9/4/2025Initiated Coverage$17.19$60.00Buy$00.0000.00% ROIAKROAkero Therapeutics9/4/2025Initiated Coverage$45.62$72.00Buy$0.0000.00% ROIETNB89BIO9/4/2025Initiated Coverage$9.24$32.00Buy$0.0000.00% ROISVRASavara9/3/2025Boost Price Target$3.39$8.00Buy$0.0000.00% ROIWVEWAVE Life Sciences9/3/2025Reiterated Rating$7.55$22.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
